- Home
- CBAN vs CERS Comparison
CBAN vs CERS Comparison
Compare CBAN & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBAN
- CERS
- Stock Information
- Founded
- CBAN 1975
- CERS 1991
- Country
- CBAN United States
- CERS United States
- Employees
- CBAN N/A
- CERS N/A
- Industry
- CBAN Major Banks
- CERS EDP Services
- Sector
- CBAN Finance
- CERS Technology
- Exchange
- CBAN Nasdaq
- CERS Nasdaq
- Market Cap
- CBAN 273.0M
- CERS 271.4M
- IPO Year
- CBAN 1998
- CERS 1997
- Fundamental
- Price
- CBAN $17.05
- CERS $1.48
- Analyst Decision
- CBAN
- CERS Strong Buy
- Analyst Count
- CBAN 0
- CERS 2
- Target Price
- CBAN N/A
- CERS $3.50
- AVG Volume (30 Days)
- CBAN 51.5K
- CERS 1.4M
- Earning Date
- CBAN 07-23-2025
- CERS 07-31-2025
- Dividend Yield
- CBAN 2.68%
- CERS N/A
- EPS Growth
- CBAN 14.66
- CERS N/A
- EPS
- CBAN 1.43
- CERS N/A
- Revenue
- CBAN $113,756,000.00
- CERS $185,144,000.00
- Revenue This Year
- CBAN $18.25
- CERS $24.95
- Revenue Next Year
- CBAN $7.59
- CERS $8.48
- P/E Ratio
- CBAN $11.97
- CERS N/A
- Revenue Growth
- CBAN 3.33
- CERS 13.06
- 52 Week Low
- CBAN $11.93
- CERS $1.12
- 52 Week High
- CBAN $18.49
- CERS $2.54
- Technical
- Relative Strength Index (RSI)
- CBAN 67.86
- CERS 59.30
- Support Level
- CBAN $16.45
- CERS $1.31
- Resistance Level
- CBAN $17.38
- CERS $1.50
- Average True Range (ATR)
- CBAN 0.39
- CERS 0.08
- MACD
- CBAN 0.17
- CERS 0.01
- Stochastic Oscillator
- CBAN 86.13
- CERS 88.64
About CBAN Colony Bankcorp Inc.
Colony Bankcorp Inc is a bank holding company. The bank provides a broad range of banking services to its retail and commercial customers. Its product line includes loans to small and medium-sized businesses, residential and commercial construction and land development loans, commercial real estate loans, agri-business and production loans, residential mortgage loans, consumer loans, and a variety of demand, savings, and time deposit products. The company's segments include the Banking Division, Retail Mortgage Division and small business specialty lending divisions. It generates maximum revenue from the Banking Division.
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.